# Stem Cell Research * **Definition:** A field of medical research focused on the use of stem cells to regenerate damaged tissues and organs, with potential applications in treating various diseases, including neurodegenerative disorders. * **Taxonomy:** Healthcare Topics / Stem Cell Research ## News * Selected news on the topic of **Stem Cell Research**, for healthcare technology leaders * 2.6K news items are in the system for this topic * Posts have been filtered for tech and healthcare-related keywords | Date | Title | Source | | --- | --- | --- | | 5/27/2025 | [**A collaborative initiative by ISSCR toward responsible adoption of stem cell models**](https://www.news-medical.net/news/20250527/A-collaborative-initiative-by-ISSCR-toward-responsible-adoption-of-stem-cell-models.aspx) | [[News Medical Net]] | | 5/27/2025 | [**News on embryonic stem cell research - Medical Xpress**](https://medicalxpress.com/tags/embryonic+stem+cell+research/page5.html?deviceType=mobile) | [[MedicalXpress]] | | 5/13/2025 | [**Maryland Stem Cell Research Fund Awards Over $18 Million to Drive Breakthroughs in ...**](https://www.prnewswire.com/news-releases/maryland-stem-cell-research-fund-awards-over-18-million-to-drive-breakthroughs-in-regenerative-medicine-302453974.html) | [[PR Newswire]] | | 4/24/2025 | [**Tiny CRISPR tool opens door to faster, simpler plant genome editing**](https://phys.org/news/2025-04-tiny-crispr-tool-door-faster.html) | [[Phys Org]] | | 4/24/2025 | [**3D Cell Culture Market Projected to Reach USD 3.80 Billion by 2030, Driven by Advancements in Drug Discovery and Regenerative Medicine**](http://prsync.com/maximize-market-research-company/d-cell-culture-market-projected-to-reach-usd--billion-by--driven-by-advancements-in-drug-discovery-and-regenerative-medicine-4726630/) | [[PRSync]] | | 4/16/2025 | [**Breakthrough method allows stem cell treatment for critically ill patients on ECMO**](https://www.news-medical.net/news/20250416/Breakthrough-method-allows-stem-cell-treatment-for-critically-ill-patients-on-ECMO.aspx) | [[News Medical Net]] | | 3/27/2025 | [**News on stem cell research**](https://phys.org/tags/stem+cell+research/) | [[Phys Org]] | | 3/7/2025 | [**The Future of Biotechnology: Medical, Food Technology, and Bioinformatics Innovations**](https://medium.com/@sourabh.more_60784/the-future-of-biotechnology-medical-food-technology-and-bioinformatics-innovations-37c067197fbb) | [[Medium]] | | 2/18/2025 | [**At the HIMSS25 AI In Healthcare Forum, tech and tactics**](https://www.healthcareitnews.com/news/himss25-ai-healthcare-forum-tech-and-tactics) | [[Healthcare IT News]] | | 2/11/2025 | [**AI-Powered Healthcare: Breakthroughs, Policies & Future Trends - Raouf Hajji, MD, PhD.**](https://www.linkedin.com/pulse/ai-powered-healthcare-breakthroughs-policies-future-hajji-md-phd--oaanf) | [[Linkedin]] | | 1/31/2025 | [**High Throughput Screening (HTS) Market to Grow by USD 19.9 Billion (2024-2028), Boosted by Rising R&D Investments, with AI Redefining Market Landscape - Technavio**](https://www.prnewswire.com/news-releases/high-throughput-screening-hts-market-to-grow-by-usd-19-9-billion-2024-2028-boosted-by-rising-rd-investments-with-ai-redefining-market-landscape---technavio-302364447.html) | [[PR Newswire]] | | 1/23/2025 | [**Global Matrigel Market Soars with a CAGR of 11.5 Insights on Phenol Red and Phenol Red-Free Applications - Valuates Reports**](https://www.prnewswire.com/news-releases/global-matrigel-market-soars-with-a-cagr-of-11-5--insights-on-phenol-red-and-phenol-red-free-applications---valuates-reports-302358775.html) | [[PR Newswire]] | | 12/18/2024 | [**Carbon Dioxide Incubators Market 2024-2032: Global Size, Share, Growth, Trends and Forecast**](http://prsync.com/imarc-group/carbon-dioxide-incubators-market---global-size-share-growth-trends-and-forecast-4511761/) | [[PRSync]] | | 11/26/2024 | [**3D Cell Culture Market Global Research Report 2024-2029 - Yahoo Finance**](https://finance.yahoo.com/news/3d-cell-culture-market-global-093800021.html) | [[Yahoo Finance]] | | 11/24/2024 | [**3D Cell Culture Global Market Overview 2024-2030: Revolutionizing Medical Research Shaping the Future of Drug Discovery and Tissue Engineering**](https://finance.yahoo.com/news/3d-cell-culture-global-market-120600413.html) | [[Yahoo Finance]] | | 10/30/2024 | [**KFSHRC Contributes to Global Healthcare Innovation through Strategic Partnerships**](https://www.globenewswire.com/news-release/2024/10/30/2971782/0/en/KFSHRC-Contributes-to-Global-Healthcare-Innovation-through-Strategic-Partnerships.html) | [[Globe Newswire]] | | 10/23/2024 | [**The Human Platelet Lysate market is projected to grow by USD 0.011 Million from 2024-2028, driven by AI and the rising prevalence of chronic diseases - Technavio**](https://www.prnewswire.com/news-releases/the-human-platelet-lysate-market-is-projected-to-grow-by-usd-0-011-million-from-2024-2028--driven-by-ai-and-the-rising-prevalence-of-chronic-diseases---technavio-302283494.html) | [[PR Newswire]] | | 10/23/2024 | [**The Human Platelet Lysate market is projected to grow by USD 0.011 Million from 2024 ...**](https://finance.yahoo.com/news/human-platelet-lysate-market-projected-211000892.html) | [[Yahoo Finance]] | | 10/22/2024 | [**Pioneering Technological Developments Propel Regenerative Medicine Forward**](https://finance.yahoo.com/news/pioneering-technological-developments-propel-regenerative-080100178.html) | [[Yahoo Finance]] | | 9/19/2024 | [**Cell Harvesting Market Size alysis - By Product Type, By Application, By Region - Forecasts (2024 - 2032)**](http://prsync.com/akvis-intelligence-llp/cell-harvesting-market-size--share-analysis---by-product-type-by-application-by-region---forecasts-----4288786/) | [[PRSync]] | | 9/17/2024 | [**Maryland Stem Cell Research Commission Announces $4.5 Million in Grants to Accelerate Stem Cell Innovations**](https://www.prnewswire.com/news-releases/maryland-stem-cell-research-commission-announces-4-5-million-in-grants-to-accelerate-stem-cell-innovations-302250682.html) | [[PR Newswire]] | | 9/17/2024 | [**News on stem cell research**](https://medicalxpress.com/tags/stem+cell+research/) | [[MedicalXpress]] | | 8/11/2024 | [**German Stem Cell Expert Leads Delegation to Boost Sino-German Health & Educational ...**](https://www.prnewswire.com/news-releases/german-stem-cell-expert-leads-delegation-to-boost-sino-german-health--educational-cooperation-302219556.html) | [[PR Newswire]] | | 8/11/2024 | [**German Stem Cell Expert Leads Delegation to Boost Sino-German Health & Educational Cooperation**](https://www.prnewswire.com/news-releases/german-stem-cell-expert-leads-delegation-to-boost-sino-german-health--educational-cooperation-302219577.html) | [[PR Newswire]] | | 7/18/2024 | [**ACROBiosystems Launches GMP Brand Resilient Supply at ISSCR to Accelerate Cell and Gene Therapy Development**](https://www.prnewswire.com/news-releases/acrobiosystems-launches-gmp-brand-resilient-supply-at-isscr-to-accelerate-cell-and-gene-therapy-development-302200459.html) | [[PR Newswire]] | ## Topic Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **New York Stem Cell Foundation (NYSCF)**: A leading organization in stem cell research, focusing on advancing the understanding of diseases and developing new therapies. - **StemCardia**: A biotechnology company focused on developing therapies for heart failure through stem cell technology. - **Maryland Stem Cell Research Commission**: An organization that allocates funding to promote stem cell research and technology in Maryland. - **UCLA**: A prominent research university involved in significant studies related to stem cell applications in treating diseases. - **Maryland Stem Cell Research Commission (MSCRC)**: Funding organization supporting innovation in regenerative medicine through grants for stem cell research. - **AcuraStem**: A biotechnology company dedicated to developing innovative treatments for neurodegenerative diseases, focusing on stem cell technologies. - **Lineage Cell Therapeutics**: A biotechnology company focused on developing regenerative medicine therapies using stem cells. - **UCLA Health**: A leading research institution focusing on innovative therapies, including stem cell research for glioblastoma. - **Dr. Joshua Weiser**: An attorney and expert in embryonic stem cell laws, advocating for ethical guidelines and federal support for stem cell research. - **GIOSTAR**: A San Diego-based organization specializing in stem cell research, focusing on developing therapies for various conditions, including Type II diabetes. - **SKAN Research Trust**: Collaborating with Happiest Health and Manipal Academy of Higher Education on stem cell research and biotherapeutics. - **Jeanne Loring**: A prominent figure in human stem cell research recognized for her contributions to regenerative medicine. - **California Institute for Regenerative Medicine (CIRM)**: A state agency in California that funds stem cell research and aims to accelerate the development of regenerative medicine therapies. - **Novartis International AG**: A global healthcare company that develops and markets innovative medicines, including those based on stem cell research. - **NMDP**: A global nonprofit leader in cell therapy focused on enhancing operational excellence and expanding access to stem cell therapies. - **Mesoblast Limited**: A regenerative medicine company focused on developing innovative therapies based on stem cell technology. - **Takara Bio USA Holdings, Inc.**: A biotechnology company that specializes in innovative life science products, including stem cell research and next-generation sequencing. ### Partnerships and Collaborations - **AcuraStem and Research Organizations**: AcuraStem collaborates with various organizations, including the California Institute of Regenerative Medicine, to develop treatments for neurodegenerative diseases. - **Wisconsin National Primate Research Center and Morgridge Institute for Research**: Developed a universal vascular graft using stem cell-derived endothelial cells to improve surgical options for cardiovascular diseases. - **Keck School of Medicine and StemCardia**: A partnership aimed at developing new cellular and genetic therapies for heart failure. - **Quantiphi and Transcell**: Strategic partnership to enhance safety profiling of novel molecules using human stem cell-based microphysiologies. - **German and Chinese Delegation**: A collaboration to enhance international health cooperation in stem cell research and biotechnology. - **Lineage Cell Therapeutics and Eterna Therapeutics**: Partnered to develop beta-2 microglobulin-deficient iPSC lines for CNS disorders. - **2redWinery and Hollander Foundation**: Conducting a crowdfunding campaign to support prostate cancer research, with proceeds directed towards stem cell research initiatives. - **EUDA Health and Guangdong Cell Biotech**: Exploring a joint venture to combine digital healthcare with stem cell treatments in Southeast Asia. - **SKAN Research Trust and Happiest Health**: Signed a Memorandum of Understanding to collaborate on academics and research, focusing on microbiome studies and stem cell research. - **Professor Bernat Soria's Clinical Team**: Developed the CIBA method for delivering cell therapies to patients on ECMO, showcasing collaboration among multiple institutions. - **KFSHRC and Saudi Space Commission**: Collaborating on stem cell research aboard the International Space Station to enhance telemedicine and remote healthcare. - **NMDP Leadership Appointments**: Katherine Heyerdahl and Jim Graham appointed to enhance operational excellence and drive the mission of saving lives through stem cell therapy. - **CIRM and Industry Partnerships**: CIRM emphasizes collaborative innovation and partnerships between academia and industry to enhance the development and commercialization of regenerative medicine therapies. - **NYSCF and Janssen Research & Development**: This partnership aims to leverage AI-powered platforms for drug discovery targeting neurodegenerative diseases, enhancing the understanding of these conditions and expediting treatment development. - **NurExone Biologic Inc.**: Participating in multiple conferences to showcase advancements in exosome therapies and regenerative medicine. - **OmniaBio and MEDIPOST**: Collaboration for manufacturing CARTISTEM product for treating knee cartilage defects. - **Factor Bioscience and Eterna Therapeutics**: Entered an exclusive license and collaboration agreement to develop advanced cell therapy candidates. - **GC Cell and Bifarma**: Strategic partnership to facilitate the entry of autologous T-cell therapy into Indonesia. - **CIRM's Strategic Allocation Framework**: A framework that encourages collaborations between academic institutions and companies to maximize the impact of funding. ### Innovations, Trends, and Initiatives - **Stem Cell Therapy Market**: Projected to grow significantly, driven by advancements in regenerative medicine, increased research investments, and a rising demand for innovative treatments. - **Advancements in Stem Cell Research**: Significant growth drivers for regenerative medicine, enabling treatments for various diseases through tissue regeneration. - **Stem Cell Market Growth**: The global stem cell market is projected to grow from USD 15.4 billion in 2023 to USD 38.1 billion by 2032, driven by applications in regenerative medicine and drug discovery. - **Technological Innovations**: Advancements in stem cell harvesting, cryopreservation, and tissue engineering are enhancing treatment efficacy and accessibility. - **Advancements in Stem Cell Therapy**: The global Stem Cell Therapy Market is projected to grow at a CAGR of 13.95% from 2024 to 2030, driven by regenerative medicine and increased funding. - **Market Growth**: The global stem cell therapy market is projected to grow from USD 12.5 billion in 2023 to USD 31.33 billion by 2032, driven by advancements in regenerative medicine. - **AI in Stem Cell Research**: Artificial intelligence is being utilized for real-time tracking and refined imaging of stem cells, enhancing therapeutic applications. - **CRISPR-Cas9 Technology**: Transforming regenerative medicine by allowing precise genetic modifications, enhancing stem cell therapies. - **Regulatory Support**: Increased regulatory approvals for new stem cell therapies are boosting market confidence and growth. - **CRISPR/Cas9 Technology**: Advancements in gene editing methods driving the use of induced pluripotent stem cells (iPSCs) in regenerative medicine. - **Induced Pluripotent Stem Cells (iPSCs)**: Advancements in iPSCs are enhancing treatment options and overcoming previous limitations in regenerative medicine. - **Regenerative Medicine Market Growth**: The global regenerative medicine market is projected to grow significantly, driven by advancements in stem cell therapies and increased investment. - **3D Cell Culture Technology**: Projected growth driven by demand for physiologically relevant in vitro models, particularly in stem cell research and tissue engineering. - **AI in Drug Discovery**: The integration of AI in stem cell research is expected to accelerate the discovery of new treatments, particularly for neurodegenerative diseases. - **LiCellMo Technology**: Developed by PHC Corporation, this technology allows real-time visualization of metabolic changes in cell cultures, enhancing research in stem cell metabolism. - **3D Cell Culture Techniques**: Gaining traction for their ability to mimic natural tissue environments, enhancing research in drug screening and tissue engineering. - **Universal Vascular Graft Development**: Innovative graft technology using stem cell-derived cells aims to address limitations of current vascular grafts, enhancing surgical options for patients. - **3D Cell Culture**: An emerging technology that creates a three-dimensional environment for cell growth, expected to see increased demand in regenerative medicine. - **Flow Cytometry Advancements**: Technological advancements in flow cytometry are enhancing the analysis of stem cell cultures and improving diagnostics in various diseases. - **Human Platelet Lysate Market**: Experiencing growth due to increased investments in stem cell research, with a focus on high-quality cell culture supplements for regenerative medicine. ### Challenges and Concerns - **Ethical Concerns**: Stem cell research often faces ethical debates regarding the source of stem cells and their use in therapies. - **Ethical Challenges**: Concerns surrounding the use of stem cells, particularly embryonic stem cells, which may hinder research and development. - **Ethical Issues**: Ethical concerns surrounding the use of stem cells continue to pose challenges for research and market growth. - **Ethical Issues in Stem Cell Research**: Ongoing ethical considerations surrounding the use of embryonic stem cells pose challenges for research and policy development. - **Fraudulent Stem Cell Clinics**: Legal actions against fraudulent clinics are infrequent, despite the rapid growth of unproven stem cell therapies, raising concerns about patient safety and misinformation. - **Regulatory Hurdles**: The development of stem cell therapies faces challenges related to regulatory approvals, which can slow down the translation of research into clinical applications. - **Market Accessibility**: Despite advancements, equitable access to stem cell therapies remains a concern, particularly in underserved regions. - **High Product Costs**: A significant barrier to the widespread adoption of stem cell therapies and technologies. - **Regulatory Challenges**: Complex regulatory requirements and limited healthcare access in developing countries hinder the growth of stem cell technologies. - **Regulatory Uncertainties**: Challenges in navigating regulatory frameworks can hinder the development and approval of stem cell therapies. - **High Treatment Costs**: Significant restraints in the stem cell market due to high costs limiting access to therapies, particularly in emerging markets. - **Cancer Risk in PSC Therapies**: Pluripotent stem cell therapies are associated with cancer risk post-transplantation, necessitating further research. - **Workforce Shortages**: Lack of skilled professionals in emerging markets hindering the growth of the stem cell research sector. - **Funding Allocation**: Ensuring effective allocation of funding to maximize impact in regenerative medicine remains a challenge for organizations like CIRM.